LifeLabs Buys Centogene's Canadian Genetic Testing Business | GenomeWeb

NEW YORK (GenomeWeb News) – LifeLabs Medical Laboratory Services today announced it has acquired the Canadian business of Centogene for an undisclosed amount.

Germany-based Centogene provides genetic testing for inherited diseases and performs testing for a number of genetic centers in Canada. During the next few months, Centogene's test portfolio will be transitioned to Toronto-based LifeLabs, and Centogene's services will continue uninterrupted to clients in Canada, LifeLabs said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.